{
    "additionDate": "2020-01-09T18:23:06Z",
    "bioagentsCURIE": "bioagents:AESA",
    "bioagentsID": "AESA",
    "confidence_flag": "agent",
    "description": "A web agent which provides several novel survival analysis approaches. It computes the gene expression composite score of a set of genes for survival analysis and utilizes permutation test or cross-validation to assess the significance of log-rank statistic and the degree of over-fitting.",
    "editPermission": {
        "type": "public"
    },
    "function": [
        {
            "operation": [
                {
                    "term": "Expression analysis",
                    "uri": "http://edamontology.org/operation_2495"
                },
                {
                    "term": "Standardisation and normalisation",
                    "uri": "http://edamontology.org/operation_3435"
                }
            ]
        }
    ],
    "homepage": "http://innovebioinfo.com/Databases/TCGA_Mutation_ExpressionDB/Mutationdb_Search5.php",
    "lastUpdate": "2021-01-14T15:09:02Z",
    "name": "Advanced Expression Survival Analysis (AESA)",
    "owner": "Pub2Agents",
    "publication": [
        {
            "doi": "10.1080/15476286.2019.1679585",
            "metadata": {
                "abstract": "© 2019 Informa UK Limited, trading as Taylor & Francis Group.Non-coding RNAs occupy a significant fraction of the human genome. Their biological significance is backed up by a plethora of emerging evidence. One of the most robust approaches to demonstrate non-coding RNA’s biological relevance is through their prognostic value. Using the rich gene expression data from The Cancer Genome Altas (TCGA), we designed Advanced Expression Survival Analysis (AESA), a web agent which provides several novel survival analysis approaches not offered by previous agents. In addition to the common single-gene approach, AESA computes the gene expression composite score of a set of genes for survival analysis and utilizes permutation test or cross-validation to assess the significance of log-rank statistic and the degree of over-fitting. AESA offers survival feature selection with post-selection inference and utilizes expanded TCGA clinical data including overall, disease-specific, disease-free, and progression-free survival information. Users can analyse either protein-coding or non-coding regions of the transcriptome. We demonstrated the effectiveness of AESA using several empirical examples. Our analyses showed that non-coding RNAs perform as well as messenger RNAs in predicting survival of cancer patients. These results reinforce the potential prognostic value of non-coding RNAs. AESA is developed as a module in the freely accessible analysis suite MutEx. Abbreviation: ACC: Adrenocortical Carcinoma (n = 92); BLCA: Bladder Urothelial Carcinoma (n = 412); BRCA: Breast Invasive Carcinoma (n = 1098); CESC: Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (n = 307); CHOL: Cholangiocarcinoma (n = 51); COAD: Colon Adenocarcinoma (n = 461); DLBC: Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (n = 58); ESCA: Oesophageal Carcinoma (n = 185); GBM: Glioblastoma Multiforme (n = 617); HNSC: Head and Neck Squamous Cell Carcinoma (n = 528); KICH: Kidney Chromophobe (n = 113); KIRC: Kidney Renal Clear Cell Carcinoma (n = 537); KIRP: Kidney Renal Papillary Cell Carcinoma (n = 291); LAML: Acute Myeloid Leukaemia (n = 200); LGG: Brain Lower Grade Glioma (n = 516); LIHC: Liver Hepatocellular Carcinoma (n = 377); LUAD: Lung Adenocarcinoma (n = 585); LUSC: Lung Squamous Cell Carcinoma (n = 504); MESO: Mesothelioma (n = 87); OV: Ovarian Serous Cystadenocarcinoma (n = 608) PAAD: Pancreatic Adenocarcinoma (n = 185); PCPG: Pheochromocytoma and Paraganglioma (n = 179); PRAD: Prostate Adenocarcinoma (n = 500); READ: Rectum Adenocarcinoma (n = 172); SARC: Sarcoma (n = 261); SKCM: Skin Cutaneous Melanoma (n = 470); STAD: Stomach Adenocarcinoma (n = 443); TGCT: Testicular Germ Cell Tumours (n = 150); THCA: Thyroid Carcinoma (n = 507) THYM: Thymoma (n = 124); UCEC: Uterine Corpus Endometrial Carcinoma (n = 560); UCS: Uterine Carcinosarcoma (n = 57); UVM: Uveal Melanoma (n = 80).",
                "authors": [
                    {
                        "name": "Edwards J."
                    },
                    {
                        "name": "Guo Y."
                    },
                    {
                        "name": "He J."
                    },
                    {
                        "name": "Hill D."
                    },
                    {
                        "name": "Kang H."
                    },
                    {
                        "name": "Ness S."
                    },
                    {
                        "name": "Oyebamiji O."
                    },
                    {
                        "name": "Ping J."
                    },
                    {
                        "name": "Shi J."
                    },
                    {
                        "name": "Ye B."
                    },
                    {
                        "name": "Ye F."
                    },
                    {
                        "name": "Yu H."
                    },
                    {
                        "name": "Zhao Y.-Y."
                    }
                ],
                "citationCount": 5,
                "date": "2020-11-01T00:00:00Z",
                "journal": "RNA Biology",
                "title": "Advancing Pan-cancer Gene Expression Survial Analysis by Inclusion of Non-coding RNA"
            },
            "pmid": "31607216"
        }
    ],
    "agentType": [
        "Web application"
    ],
    "topic": [
        {
            "term": "Functional, regulatory and non-coding RNA",
            "uri": "http://edamontology.org/topic_0659"
        },
        {
            "term": "Oncology",
            "uri": "http://edamontology.org/topic_2640"
        },
        {
            "term": "RNA-Seq",
            "uri": "http://edamontology.org/topic_3170"
        },
        {
            "term": "Transcription factors and regulatory sites",
            "uri": "http://edamontology.org/topic_0749"
        },
        {
            "term": "Transcriptomics",
            "uri": "http://edamontology.org/topic_3308"
        }
    ],
    "validated": 1
}
